Showing 2 of 10 years of data. Sign up free for 5 years of history.
View Plans2-year trend showing gross, operating, and net profit margins
Syngene's net profit margin of 8.3% in FY2026 reflects thin profitability, with operating margin at 14.1% and gross margin at 75.9%.
In FY 2026, Syngene posted a gross margin of 75.9%, an operating margin of 14.1%, a net margin of 8.3%. Gross Margin = (Revenue - COGS) / Revenue; Operating Margin = EBIT / Revenue; Net Margin = Net Income / Revenue. Typical healthy ranges: Gross 20-40%, Operating 10-20%, Net 5-10%+. Consistent or improving margins indicate strong competitive positioning.
2-year trend showing revenue, gross profit, and net profit
Syngene's revenue grew 2.6% to 38.09B in FY2026, but net profit declined 36.2% to 3.17B — indicating margin compression.
In FY 2026, Syngene's revenue grew by 2.6% year-over-year. Revenue is total income from operations. Gross Profit is revenue minus cost of goods. Net Profit is the bottom line after all expenses. Consistent growth across all three signals a healthy, expanding business.
2-year trend showing shareholder returns
Syngene's ROE of 6.5% in FY2026 indicates below-average shareholder returns.
In FY 2026, Syngene reported an ROE of 6.5%. ROE = (Net Income / Shareholders' Equity) x 100. Measures how efficiently the company turns equity into profit. Above 15% is generally strong; above 25% is excellent. Very high ROE may signal high leverage — check alongside debt levels.
2-year trend comparing profitability with cash generation
Syngene's FCF/NI ratio of 1.80x in FY2026 indicates high-quality, cash-backed earnings.
In FY 2026, Syngene's free cash flow exceeded net income. Free Cash Flow = Operating Cash Flow - Capital Expenditure. When FCF exceeds net income, it suggests high-quality, cash-backed earnings. Persistent gaps may indicate aggressive accounting or heavy capex needs.
2-year trend comparing profitability with cash from operations
Syngene's OCF/NI ratio of 2.89x in FY2026 indicates strong cash collection and working capital efficiency.
In FY 2026, Syngene's operating cash flow exceeded net income. Operating Cash Flow is the actual cash from core operations. OCF exceeding net income signals strong cash collection. OCF trailing net income may indicate aggressive revenue recognition or working capital issues.
Measure a company's financial leverage, liquidity, and ability to meet financial obligations.
2-year trend showing short-term liquidity position
Syngene's current ratio of 1.38x in FY2026 indicates healthy short-term liquidity.
In FY 2026, Syngene reported a current ratio of 1.38. Current Ratio = Current Assets / Current Liabilities. Measures short-term liquidity. A ratio of 1.5-3.0 is generally healthy; below 1.0 signals liquidity risk; above 3.0 may indicate underutilized assets.
2-year trend showing ability to service debt
Syngene's interest coverage ratio of 11.0x in FY2026 indicates comfortable debt servicing capacity.
In FY 2026, Syngene reported an interest coverage ratio of 11.0x. Interest Coverage = EBIT / Interest Expense. Shows how many times operating profit covers interest payments. Above 5x is comfortable; below 1.5x signals potential difficulty servicing debt.
2-year trend showing financial leverage and capital structure
Syngene's debt-to-equity ratio of 0.09x in FY2026 reflects a conservative, low-leverage capital structure.
In FY 2026, Syngene reported a debt-to-equity ratio of 0.09. Debt-to-Equity = Total Debt / Total Equity. Below 1.0 is conservative; 1.0-2.0 is moderate; above 2.0 indicates higher financial risk. Capital-intensive industries naturally carry higher ratios.
2-year trend showing total debt with year-over-year changes
Syngene's debt decreased 20.7% YoY in FY2026 — positive deleveraging improves financial flexibility.
In FY 2026, Syngene's total debt decreased by 20.7% year-over-year. Total Debt includes short-term debt, long-term loans, debentures, and capital leases. YoY changes (shown as percentages) reveal whether the company is leveraging up or deleveraging.
Year-over-year change in diluted shares outstanding
Syngene's diluted shares remained virtually unchanged in FY2026.
Over 2 years (FY2025–FY2026), diluted shares remained essentially unchanged at 402.41M.
In FY 2026, Syngene's diluted shares increased by 0.0% year-over-year. Diluted Shares accounts for stock options, warrants, and convertibles. Positive YoY change means dilution (red); negative means buybacks (green). Consistent dilution above 5% annually is a red flag.
You're viewing 2 years of data. Upgrade to access 10 years of financial ratios, margins, and performance metrics.
Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: FY 2026